IP Library Granted Patent US 10,441,625
Granted Patent B2
US 10,441,625 · App. 16/035,274 · Granted Oct 15, 2019

Materials and methods for treatment of inflammation

Inventors: Theodore E. Maione (Green Island, NY); Constantine Basil Maglaris (New Canaan, CT)
Assignee: CYTOGEL PHARMA, LLC
A61K38/07
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,441,625
App. No.
16/035,274
Granted
Oct 15, 2019
Kind
B2
Abstract

The subject invention pertains to peptides and salts thereof that are useful as anti-inflammatory agents and to compositions containing such peptides and salts as active ingredients. Specifically exemplified herein are endomorphin-1 peptide (EM-1), analogs and salts thereof, and uses for modulation of calcitonin gene-related peptide (CGRP) production and/or substance P (SP) and for treatment of inflammation, particularly neurogenic inflammation.

Claims (2)

1. A method for treating a human subject to reduce neurogenic inflammation, wherein said method comprises administering, intravenously, to a human subject in need of treatment of neurogenic inflammation, an effective amount of the acetate salt of SEQ ID NO:13.

2. The method, according to claim 1 , further comprising administering an anti-inflammatory agent selected from the group consisting of a steroidal compound, hydrocortisone, a non-steroidal anti-inflammatory compound, acetylsalicylic acid (aspirin), ibuprofen, acetaminophen, and indomethacin, wherein the anti-inflammatory agent is administered before, during, or after the administration of said peptide or salt thereof.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 3, 2019
From: MAIONE, THEODORE E.; MAGLARIS, CONSTANTINE BASIL
To: CYTOGEL PHARMA, LLC
Reel/Frame 048486/0492 →
Continuity (3)
Continuation 13113392 · May 23, 2011
Provisional Application 61347102 · May 21, 2010
Related Publication 20180311303A1 · Nov 1, 2018